Descriptor English: | Sarcoidosis, Pulmonary | ||||
Descriptor Spanish: |
Sarcoidosis Pulmonar
| ||||
Descriptor Portuguese: | Sarcoidose Pulmonar | ||||
Descriptor French: | Sarcoïdose pulmonaire | ||||
Entry term(s): |
Pulmonary Sarcoidoses Pulmonary Sarcoidosis Sarcoidoses, Pulmonary |
||||
Tree number(s): |
C08.381.483.725 C15.604.515.827.725 C20.543.418.575.725 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D017565 | ||||
Scope note: | Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431) |
||||
Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||
Previous Indexing: |
Lung Diseases (1966-1993) Sarcoidosis (1966-1993) |
||||
Public MeSH Note: | 94 |
||||
History Note: | 94 |
||||
Entry Version: | SARCOIDOSIS PULM |
||||
DeCS ID: | 31059 | ||||
Unique ID: | D017565 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1994/01/01 | ||||
Date of Entry: | 1993/03/03 | ||||
Revision Date: | 2009/07/06 |
|
Sarcoidosis, Pulmonary
- Preferred
Concept UI |
M0026628 |
Scope note | Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431) |
Preferred term | Sarcoidosis, Pulmonary |
Entry term(s) |
Pulmonary Sarcoidoses Pulmonary Sarcoidosis Sarcoidoses, Pulmonary |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey